Search

Author/Creator Warren, Edus H

1. Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study. Issue 8 (August 2021)

Authors:
Lynch, Ryan C; Cassaday, Ryan D; Smith, Stephen D; Fromm, Jonathan R; Cowan, Andrew J; Warren, Edus H; Shadman, Mazyar S; Shustov, Andrei; Till, Brian G; Ujjani, Chaitra S; Libby, Edward N; Philip, Mary; Coye, Hilary; Martino, Christen N; Bhark, Sandra L; Morris, Karolyn; Rasmussen, Heather; Behn...
Journal:
Lancet
Issue:
Volume 8:Issue 8(2021)
Page Start:
e562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells. Issue 1 (14th October 2014)

Authors:
Pollack, Seth M; Jones, Robin L; Farrar, Erik A; Lai, Ivy P; Lee, Sylvia M; Cao, Jianhong; Pillarisetty, Venu G; Hoch, Benjamin L; Gullett, Ashley; Bleakley, Marie; Conrad, Ernest U; Eary, Janet F; Shibuya, Kendall C; Warren, Edus H; Carstens, Jason N; Heimfeld, Shelly; Riddell, Stanley R; Yee, C...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2:Issue 1(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗